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The MM50 Racetrack Microtron, suited for advanced three-dimensional conformal radiotherapy techniques, is a complex 
machine in various respects. Therefore, for a number of gantry angles, daily quality control of the absolute output and fluence 
profiles of the scanned beams are mandatory. For the applied photon beams, a fast method for these daily checks, based on 
dosimetric measurements with the Philips SRI-100 Electronic Portal Imaging Device (EPID), has been developed and tested. Open 
beams are checked for four different gantry angles; for gantry angle 0, a wedged field is checked as well. Performing and analyzing 
the measurements akes about 10 mm. The applied EPID has favourable characteristics for dosimetric quality control 
measurements: absolute output measurements reproduce within 0.5% (1 SD) and the reproducibility of relative (2D) beam profile 
measurements is 0.2% (1 SD). The day-to-day sensitivity stability over a period of one month is 0.6% (1 SD). Measured grey scale 
values are within 0.2% linear with the applied dose. The 2D fluence profile of the 25 MV photon beam of the MM50 is very stable 
in time: during a period of 5 months a maximum fluctuation of 2.2% has been observed. Once, a deviation in the cGy/MU-value 
of 6O/ was detected. There is no interlock in the MMSO-system that would have prevented patient treatment with this strongly 
deviating output. Based on the results of this study and on clinical requirements regarding acceptability of deviations of beam 
characteristics, a protocol has been developed including action levels for additional investigations and, if necessary, adjustment 
of the beam characteristics. 
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1. Introduction 
In the Dr. Daniel den Hoed Cancer Center a dual 
gantry MM50 Racetrack Microtron [5,6] has been in 
clinical use since March 1994. This device, built by Scan- 
ditronix for the application of advanced three- 
dimensional conformal radiotherapy techniques, pro- 
duces photon and electron beams with energies from 10 
up to 50 M(e)V in steps of 5 M(e)V. Both gantries are 
equipped with a double focused multileaf collimator 
(MLC) which is suitable for shaping both photon and 
electron beams [l]. The MM50 can be used in a fully 
computer-controlled multi-segment treatment mode [4]. 
Using this mode only the first segment (field) of a pa- 
tient treatment needs direct interference of the techni- 
l Corresponding author. 
cians; all parameters of the next segments, like the 
gantry and collimator angles, couch positions, field 
shape, beam energy and monitor units, are set up by the 
treatment computer. Flat photon and electron beam 
profiles are obtained by computer-controlled scanning 
of elementary beams according to fixed scanning pat- 
terns [2,3]. In addition, customized scanning patterns 
can be used to create patient-specific, intensity- 
modulated beam profiles. Individualized beam profiles 
can also be produced by means of dynamic multileaf 
collimation [7,8]. Both gantries of the MM50 are equip- 
ped with a Philips SRI-100 electronic portal imaging de- 
vice (EPID) [9]. 
The MM50 consists of a separate lectron accelerator 
and two gantries. Through an evacuated beam line of 
about 6 m the accelerated electrons are transported to 
one of both gantries where clinical photon and electron 
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beams are generated. A constant flow of a heliumnitro- 
gen mixture (99% He, 1% N2) runs through the MM50 
monitor chambers and the treatment heads to reduce 
electron scattering, yielding very narrow elementary 
electron beams [3]. 
The complex lay-out with a separate accelerator serv- 
ing two gantries, the application of beam scanning and 
the continuous gas flow through the monitor chamber 
and the treatment head definitely require a daily 
dosimetric quality control program in addition to our 
more extensive checks on a 2-weekly basis. Therefore, a 
method has been developed to perform fast dosimetric 
checks under different gantry angles using the Philips 
SRI-100 electronic portal imaging device. Measure- 
ments take place every morning before patient treatment 
starts. 
This paper deals with a description of the daily quality 
control measurements and demonstrates the suitability 
of the EPID for this purpose. The stability of the abso- 
lute output and the relative fluence profile of the 25 MV 
scanned photon beam of the MM50 have been assessed. 
A protocol for quality control measurements, based on 
the results of this study, is described. 
2. Materials and methods 
2.1. The electronic portal imaging device 
The SRI-100 is a fluoroscopic system: radiation inci- 
dent on a fluorescent screen (at a distance of 160 cm 
from the focus) is converted into an optical image which 
is digitized using a CCD-camera. The CCD-chip con- 
sists of 512 x 256 pixels, with a pixel size projected at 
isocenter’ of about 0.5 x 0.8 mm*, resulting in a maxi- 
mum field size of 25 x 19 cm2 for imaging. In order to 
improve the signal-to-noise ratio, the signals of the 
CCD-camera are accumulated on the CCD-chip and 
averaged in a frame grabber. The final image is stored 
in a PC using grey scale values in the range of O-255. 
The technical details of the EPID have been described 
by Visser et al. [9]. 
Prerequisites for dosimetric quality control measure- 
ments with an EPID are adequate reproducibility, 
stability and linearity of the measured grey scale values. 
To ensure the response of the EPID, defined as the ratio 
of a measured grey scale value and the applied portal 
dose, to be as unequivocal as possible, some precautions 
have been taken. The gain and offset of the CCD- 
camera have been set to fixed values and a fixed data ac- 
quisition time has been used. In addition, the images 
have only been corrected for dark current, which is 
measured just before irradiation starts. 
’ All pixel and field sizes mentioned in this paper are defined at 
isocenter level, i.e., at a distance of 100 cm from the focus. 
The fluorescent screen of the EPID is a 1.65 mm thick 
stainless teel plate coated with a fluorescent layer [9]. 
For a 25 MV photon beam this screen is not thick 
enough to establish a full charged particle build-up. In 
the present study this is not a problem since the EPID 
has only been used for dosimetric constancy checks. 
A fixed field size of 18 x 18 cm* has been used for 
all measurements in this study. For data reduction, aver- 
age grey scale values have been calculated for 49 areas 
of 15 x 15 mm* inside the measured EPID-image, 
yielding dosimetric data for the beam axis and for 48 
off-axis points (see Fig. 1). All software used for acquir- 
ing and analyzing the images has been written in the 
MCLcommand language of the SRI-100 system. 
In addition to the daily dosimetric checks with the 
EPID for the 18 x 18 cm2 field, the field flatness and 
symmetry are also checked for the maximum field size 
(31 x 40 cm*) as part of our 2-weekly quality control 
program. These measurements are performed along the 
two main axes using a linear detector array consisting of 
32 ionisation chambers. 
2.2. Reproducibility, stability and linearity of the EPID 
The reproducibility, stability and linearity of the 
EPID have been assessed by comparing measured grey 
scale values with absolute dose measurements at the 
beam axis. The dose measurements were performed with 
an NE-2571 ionisation chamber in a PMMA phantom 
at the depth of maximum dose with a source-to-surface 
distance of 100 cm. Since EPID and ionisation chamber 
measurements could not be performed simultaneously, 
the two types of measurements were always performed 
sequentially, keeping the interval time as short as 
possible. 
2.3. Daily quality control measurements 
For the open 25 MV scanning photon beam, EPID 
images were obtained on a daily basis for four different 
gantry angles (0,90, 180 and 270”). For gantry angle 0, 
a 60” wedged field image was measured as well to verify 
the wedge position and to check the beam penetrative 
quality. All images were acquired using a fixed dose of 
150 Monitor Units. The five fields (four open fields and 
one wedged field) were set up under computer control 
using the MM50 multi-segment treatment mode which is 
described in Section 1. 
To determine deviations in the absolute beam output 
and in the relative 2D fluence profile, each image has 
been compared with a corresponding reference image. 
This reference image reflects the absolute 2D fluence 
profile at the time of beam commissioning for a fixed 
dose of 150 MU and a cGy/MU-value of 1 for the 10 x - 
10 cm* field. Both the absolute output and the 2D 
fluence profile of the 25 MV photon beam of the MM50 
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Fig. 1. Screen output showing the definition of the 49 areas of IS x 15 mm2 in an EPID-image. The numbers represent an example of observed 
percentual deviations of measured absolute grey scale values from the corresponding values in the related reference image. 
are slightly gantry angle dependent. For clinical practice 
these dependencies are within acceptable levels and for 
treatment planning the beam data for gantry angle 0 are 
used. The use of a separate reference image for each field 
in the daily dosimetric onstancy checks eases a fast in- 
terpretation of these measurements: for each field, con- 
stancy means zero deviations with regard to its 
corresponding reference image. 
For each of the 49 areas defined in the measured im- 
ages, the percentual difference in measured grey scale 
value compared to the corresponding area in the related 
reference image has been determined. Fig. 1 shows the 
screen output of a typical measurement. Observed dif- 
ferences at the beam axis (1.4% in this example) relate 
to deviations in the absolute output of the photon beam. 
Deviations in the relative 2D fluence profile have been 
determined by correcting the 49 percentual differences 
for the observed deviation in absolute output at the 
beam axis (compare Figs. 1 and 2). 
3. Results and discussion 
3.1. Reproducibility, stability and linearity of the EPID 
The short-term reproducibility of dosimetric EPID- 
measurements has been assessed by sequential measure- 
ment of images and ionisation chamber eadings at the 
beam axis under identical conditions in a short overall 
period of time (typically 15 min). Both for the on-axis 
and off-axis points the EPID-measurements how a 
reproducibility of the measured grey scale values of 
0.5% (1 SD); the fluctuations in the ionisation chamber 
readings were negligible. A significant correlation exists 
between on-axis and off-axis fluctuations: after correc- 
ting the grey scale values in the off-axis points for the 
observed on-axis fluctuations, the remaining image-to- 
image variation for off-axis points decreases to only 
0.2% (1 SD). 
To assess the day-to-day sensitivity stability of the 
SRI-100, its response at the beam axis has been deter- 
mined, usually twice a day, for a period of 20 days. 
Measurements of one EPID-image and a few ionisation 
chamber eadings were performed for gantry angle 0 in 
a short overall period of time. The results depicted in 
Fig. 3 reveal a variation in the on-axis EPID-response of 
0.6% (1 SD), which is only slightly larger than the 
above-mentioned short-term reproducibility. 
To assess the long-term sensitivity stability of the 
SRI- 100, the response measurements have been repeated 
in a second period of 20 days. The time interval between 
the first and the second period was 60 days. Also for this 
second period a variation in the EPID-response of 0.6% 
(1 SD) was measured. However, the average response in 
the second period was 0.5% lower than in the first 
period, possibly due to radiation damage in the 
CCD-chip. 
The linearity of the EPID has been assessed for doses 
between 40 and 180 Monitor Units. From the results in 
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Fig. 2. Percentual deviations in the relative 2D fluence profile from the reference image, derived by renormalization of the data in Fig. I, assuming 
zero deviation at the beam axis. 
Fig. 4, showing the measured response at the beam axis 
as a function of MU, it is clear that the response does 
not significantly depend on the applied dose. In other 
words, the measured grey scale value increases linearly 
with the delivered dose. 
It may be concluded that the SRI-100 is suitable for 
daily dosimetric quality control measurements. No ad- 
verse interference ffects related to the combined use of 
the MM50 scanning beams and the slow scan mode of 
the CCD-camera have been observed. For at least a 
period of several weeks it is possible to derive the output 
at the beam axis from a single EPID-measurement with 
an accuracy of 0.6% (1 SD), while the relative 2D 
grey scale value/dose 
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Fig. 3. Day-today on-axis sensitivity stability of the EPID. 
fluence profile can be determined even more accurately. 
After a period of several weeks a recalibration of 
the EPID might be necessary to correct for changes in 
sensitivity. 
3.2. Daily quality control measurements 
The observed deviations in absolute on-axis output 
for gantry angle 0, measured with the EPID during a 
period of nearly 150 days, are depicted in Fig. 5. The 
sudden changes in output deviation on days 38 and 114 
are related to recalibrations of the MM50 monitor 
grey scale value/dose 
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Fig. 4. Linearity of the measured grey scale value with applied portal 
dose. 
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Fig. 5. Deviations in absolute on-axis output of the 25 MV photon 
beam, measured with the EPID for gantry angle 0. The deviation of 
6%, detected on day 105, has been omitted (see text for further 
explanation). 
chamber. Table 1 summarizes the results of 400 
measured images, equally spread over the live different 
fields. 
On day 105 an output deviation of about 6% was 
detected for each field. (In order to stick to an appropri- 
ate ordinate scale in Fig. 5, this value has not been in- 
cluded.) Checks with an ionisation chamber showed an 
output deviation of the same amount. This large devia- 
tion was a consequence of a human error related to the 
helium/nitrogen flow in the monitor chamber. For his- 
torical reasons two separate bottles are used to supply 
each gantry with this mixture: one while the MM50- 
system is switched on, the other when the system is off. 
During the weekend the ‘system-off bottle’ for one gan- 
try became mpty because the person responsible forgot 
to change it before the weekend. For this reason the con- 
stant gas flow stopped, the overpressure in the treatment 
head went down and air could leak into the treatment 
Table 1 
Overview of observed eviations from corresponding reference images 
Deviations (%) Incidence 
rate (%) 
absolute on-axis output < l 2.0 93 
deviations a(2.0-3.0) 5 
> l 3.0 2 
average off-axis profile < *0.3 96 
deviations *(0.3-0.5) 4 
> l 0.5 0 
maximum off-axis profile < *I.5 92.5 
deviations l (1.5-2.0) I 
> l 2.0 0.5 
The incidence rates indicate the percentage of the total number of 
analyzed fields (n = 400) in which a certain deviation occurred. 
off-axis beam profile deviations (%) 
I / 
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Fig. 6. Off-axis deviations in the relative 2D beam profiles for gantry 
angle 0. The dots indicate the average off-axis deviations for the 48 off- 
axis points, the bars indicate the maximum deviations. 
head and therefore also into the monitor chamber. 
When the machine was switched on after the weekend, 
the ‘system-on bottle’ was automatically connected to 
the monitor chamber. At that moment the MM50- 
system observed correct input and return gas flows 
(since the ‘system-on bottle’ was not empty) and no in- 
terlock occurred. However, it took several hours before 
all air had disappeared from the monitor chamber, 
yielding an increased sensitivity of this chamber and 
therefore a 6% too low beam output. 
The observed average and maximum deviations in the 
relative 2D beam profile, determined from the 
measurements in the 48 off-axis points, are depicted in 
Fig. 6 for gantry angle 0, and summarized in Table 1 for 
all fields. Because the average off-axis deviation was 
always less than 0.5% and the maximum observed off- 
axis deviation was 2.2%, it may be concluded that the re- 
lative 2D fluence profile is very stable. 
Wedge factors have been calculated from measured 
grey scale values at the beam axis for the open and the 
wedged field at gantry angle 0. Over the period of this 
study the measured wedge factor was constant within 
0.9% (1 SD). 
On several days, the morning quality control 
measurements were repeated in the afternoon after pa- 
tient treatment. No significant differences between re- 
sults obtained in the morning and in the afternoon have 
been observed. 
3.3. Protocol for daily quality control measurements 
Based on the results in Table 1 and on clinical require- 
ments regarding acceptability of deviations, the follow- 
ing practical protocol for future daily dosimetric quality 
control measurements has been adopted: 
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If 
* for each field the on-axis output deviation is smaller 
than 3%, 
and 
* for the five fields the average output deviation at the 
beam axis is less than 2% or between 2 and 2.5% while 
being below the 2% level the previous 2 days, 
and 
* for each field the maximum off-axis beam profile 
deviation is less than 2% or between 2 and 2.5% while 
being below the 2% level the previous 2 days, 
and 
* for each field the average off-axis deviation is less than 
0.5% or between 0.5 and 0.7% while being below the 
0.5% level the previous 2 days, 
the results are accepted and patient treatment can start. 
In all other cases, additional investigations and, if 
necessary, adjustment of the beam characteristics have 
to be performed. When this protocol had been applied 
to the daily quality control measurements described 
before, patient treatment could have started immedi- 
ately on 95% of the days. 
Daily EPID measurements should be fast. Therefore, 
only one image is measured per field and the allowed 
deviations, as described in the protocol above, are 
somewhat larger than for the checks in our 2-weekly 
quality control program. 
4. Conclusions 
Because of its characteristics, the Philips SRI-100 
Electronic Portal Imaging Device, is suitable for fast 
and accurate daily dosimetric quality control of photon 
beams under different gantry angles. Deviations in the 
absolute output and in the relative 2D fluence profiles 
are determined within 10 min for five fields. 
Despite the complexity of the MM50, the 2D fluence 
profile of the 25 MV scanned photon beam has been 
very stable for all gantry angles during a period of 5 
months: a maximum profile deviation of 2.2% was 
observed and the average profile deviation never exceed- 
ed 0.5%. Once, a deviation in the cGy/MU-value of 6% 
was detected. Only because of the performed morning 
quality control checks, could erroneous dose delivery to 
patients be avoided. Based on our experiences, a prac- 
tical protocol for future daily dosimetric quality control 
measurements has been developed. 
This paper is based on the results of measurements for 
the 25-MV photon beam of one gantry. However, at this 
moment he dosimetric hecks are also successfully per- 
formed at the other gantry. In the near future the quality 
control measurements will be extended to the IO-MV 
photon beam and geometric checks on multileaf 
collimator-defined fields will be added as well. Studies 
on the application of the SRI-100 for in vivo dosimetry 
on the MM50 have been started. 
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